TCT-444: Anti-inflammatory Effect of Arsenic Trioxide Eluting Stents in a porcine coronary model
Wei Yang,Feirong Gong,Yizhe Wu,Juying Qian,Aijun Sun,Yunzeng,Zou,Junbo Ge,Jung-Sun Kim,Maxwell E Afari,Jinyoung Ha,Armando Tellez,Krzysztof,Milewski,Gerard Conditt,Yanping Cheng,Greg L Kaluza,Qibing Wang,Jian Xie,Lynn Bailey,Serge Rousselle,Gregory,Kopia,William Easterbrook,Mark Pomeranz,Patrick Serruys
DOI: https://doi.org/10.1016/j.jacc.2011.10.454
2016-01-01
Abstract:stents. Single and OL SES eluted > 90% of sirolimus loaded by Day 60. Sirolimus elution rate and arterial content in all 3 cohorts declined quickly to similar levels by Day 3. Though OL NEVOTM stents eluted 3.7-fold more sirolimus than single NEVOTM stents by Day 1 (28.8±7.4 vs 7.7±3.1 μg), arterial content was not statistically different, indicating that local drug delivery to the artery wall from OL SES is dominated by the wall-apposed stent. This inference is supported by the fact that peak sirolimus blood level in OL NEVOTM and OL 2x-NEVOTM stents was 5.5to 9.8-fold higher than single NEVOTM stents (3.31±1.13 and 5.89±1.75 vs 0.60±0.27 ng/ml). Sirolimus levels in blood, myocardium, and peripheral organs declined below the limit of quantification by Day 60. Conclusion: Our data show that overlapping NEVOTM stents do not influence sirolimus elution rate and that wall apposition dominates local arterial delivery. Systemic sirolimus exposure remains below toxic levels at all times even for OL 2xNEVOTM stents, presumably due to fast hydrolytic degradation of free sirolimus in blood and hepatic metabolism.